These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1351201)
1. IGE-mediated reaction to hydroxocobalamin injection in patient with pernicious anaemia. de Blay F; Sager MF; Hirth C; Alt M; Chamouard P; Baumann R; Pauli G Lancet; 1992 Jun; 339(8808):1535-6. PubMed ID: 1351201 [No Abstract] [Full Text] [Related]
3. Comparison of hydroxocobalamin and cyanocobalamin in the treatment of pernicious anaemia. Chalmers JN; Shinton NK Lancet; 1965 Dec; 2(7426):1305-8. PubMed ID: 4165301 [No Abstract] [Full Text] [Related]
4. Anaphylactic reaction after injection of vitamin B12. Hovding G Br Med J; 1968 Jul; 3(5610):102. PubMed ID: 5662949 [No Abstract] [Full Text] [Related]
5. Patient variation in pernicious anaemia, as shown in a clinical trial of cyanocobalamin, hydroxocobalamin and cyanocobalamin--zinc tannate. Tudhope GR; Swan HT; Spray GH Br J Haematol; 1967 Mar; 13(2):216-28. PubMed ID: 6019807 [No Abstract] [Full Text] [Related]
6. Maintenance therapy of pernicious anaemia. Comparison of cyanocobalamin, hydroxocobalamin and a cyanocobalamin-zinc-tannate complex. Killander A; Werner I Acta Haematol; 1968; 40(6):305-14. PubMed ID: 4978697 [No Abstract] [Full Text] [Related]
8. Hydroxocobalamin. V. Prolonged maintenance of high vitamin B12 blood levels following a short course of hydroxocobalamin injections. Glass GB; Skeggs HR; Lee DH Blood; 1966 Feb; 27(2):234-41. PubMed ID: 5322750 [No Abstract] [Full Text] [Related]
11. Anaphylactic reaction to hydroxycobalamin. Branco-Ferreira M; Clode MH; Pereira-Barbosa MA; Palma-Carlos AG Allergy; 1997 Jan; 52(1):118-9. PubMed ID: 9062645 [No Abstract] [Full Text] [Related]
12. [Dosage of hydroxocobalamin (Vibeden)]. Skouby AP Ugeskr Laeger; 1970 Jan; 132(5):208-13. PubMed ID: 5446563 [No Abstract] [Full Text] [Related]
13. Hydroxocobalamin. Excretion and retention of repeated large doses in patients with pernicious anaemia. Killander A; Werner I Acta Med Scand; 1968 Nov; 184(5):393-4. PubMed ID: 5732554 [No Abstract] [Full Text] [Related]
14. Case 30-2004: a woman with paresthesias. Davies SV N Engl J Med; 2005 Jan; 352(4):419-20; author reply 419-20. PubMed ID: 15673813 [No Abstract] [Full Text] [Related]
15. Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin. Moloney FJ; Hughes R; O'Shea D; Kirby B Clin Exp Dermatol; 2008 Jul; 33(4):412-4. PubMed ID: 18498413 [TBL] [Abstract][Full Text] [Related]
16. [RETENTION OF VITAMIN B12. A COMPARATIVE STUDY OF RETENTION AFTER INTRAMUSCULAR INJECTION OF CYANOCOBALAMIN AND HYDROOXOCOBALAMIN RESPECTIVELY]. HERTZ H; KRISTENSEN HP; HOFF-JORGENSEN E Ugeskr Laeger; 1964 Apr; 126():535-41. PubMed ID: 14147554 [No Abstract] [Full Text] [Related]
17. [Comparison between the durations of the effects of the vitamin B12 preparations Betolvex and Vibeden]. Bastrup-Madsen P Ugeskr Laeger; 1973 Sep; 135(38):2037-41. PubMed ID: 4774011 [No Abstract] [Full Text] [Related]
19. Pernicious anaemia presenting as catatonia without signs of anaemia or macrocytosis. Jauhar S; Blackett A; Srireddy P; McKenna PJ Br J Psychiatry; 2010 Sep; 197(3):244-5. PubMed ID: 20807971 [TBL] [Abstract][Full Text] [Related]
20. Severe pernicious anaemia in an 8-year-old African girl. van Loon M; Postels DG; Heikens GT; Molyneux E Ann Trop Paediatr; 2009 Sep; 29(3):231-4. PubMed ID: 19689867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]